Archive -Daily News

CRISPR Therapy

CRISPR : 2017November07Tuesday

CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor ...

Playing God: "We are in the midst of a genetic revolution"

Syngenta acquires CRISPR-Cas9 gene-editing license, buys seed firm

Mail-Order CRISPR Kits Allow Absolutely Anyone to Hack DNA

A revolutionary gene-editing technology is on track to be a $10 billion market by 2025

Bioethicist: History Tells Us CRISPR Fears Are Overblown

CRISPR 2.0 Is Here, and It's Way More Precise

Combatants prepping for next skirmish in battle over CRISPR patents

Scientist Rodolphe Barrangou on riding the gene-editing wave

IPO Education Foundation Honors CRISPR-Cas9 Innovators as Inventors of the Year

Genetic Engineering: 2017November07Tuesday

How genetic engineering is affecting Earth

Playing God: "We are in the midst of a genetic revolution"

Genetic engineering 'fastest method' to save Florida citrus industry from greening disease

Genetically modified apple reaches US stores, but will consumers bite?

Trump's agriculture department reverses course on biotech rules

Science Moms Documentary Aims To Shift Parenting Narrative From Fear To Facts

Cancer Chemotherapy Resistance Stopped By Chromatin Regulation

Global Cell Therapy Research to 2026

We Shouldn't Trust New Tech. We Shouldn't Fear It, Either

Global Agricultural Micronutrients Market - Analysis, Trends & Forecasts to 2021 - Research and Markets

Gene Editing : 2017November07Tuesday

Syngenta acquires CRISPR-Cas9 gene-editing license, buys seed firm

Scientist Rodolphe Barrangou on riding the gene-editing wave

Viewpoint: 'Gattaca' reminds us that gene editing has dark possibilities

CRISPR 2.0 Is Here, and It's Way More Precise

A revolutionary gene-editing technology is on track to be a $10 billion market by 2025

Playing God: "We are in the midst of a genetic revolution"

Closing gap between rich and poor farmers: CRISPR gene editing targets disease, pests and climate

Mail-Order CRISPR Kits Allow Absolutely Anyone to Hack DNA

Combatants prepping for next skirmish in battle over CRISPR patents

Cancer Chemotherapy Resistance Stopped By Chromatin Regulation

CRISPR Therapy : 2017November07Tuesday

CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor ...

DuPont Scientist Philippe Horvath Receives Franklin Institute Science Prize

$6 million supports leukemia research

Exclusive Speaker Interview with Professor Nagy Habib

What's in the Cards for Adverum (ADVM) This Earnings Season?

Boeing and CASIS Award $500000 for Microgravity Research through MassChallenge

EPS for Abeona Therapeutics (ABEO) Expected At $-0.16; Last Week Mistras Group (MG) Coverage

Editas Medicine (EDIT) & Oramed Pharmaceuticals (ORMP) Head to Head Analysis